NewEdge Advisors’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1K | Hold |
10,600
| – | – | ﹤0.01% | 2976 |
|
|
2025
Q1 | $20.2K | Buy |
+10,600
| New | +$20.2K | ﹤0.01% | 2860 |
|
|
2024
Q2 | – | Sell |
-225
| Closed | -$848 | – | 3878 |
|
|
2024
Q1 | $848 | Buy |
+225
| New | +$848 | ﹤0.01% | 3529 |
|
|
2023
Q4 | – | Sell |
-11,050
| Closed | -$36.2K | – | 3800 |
|
|
2023
Q3 | $36.2K | Hold |
11,050
| – | – | ﹤0.01% | 2193 |
|
|
2023
Q2 | $49.5K | Buy |
11,050
+550
| +5% | +$2.46K | ﹤0.01% | 2089 |
|
|
2023
Q1 | $54.1K | Buy |
+10,500
| New | +$54.1K | ﹤0.01% | 1967 |
|